The Aporia · Companies illegally selling unapproved Eli Lily weight loss drug Retatrutide online

CBS News uncovered that companies are selling Retatrutide, an unapproved weight loss drug currently in clinical trials by Eli Lilly, illegally through online platforms to customers in the United States. Investigative reporter Daniel Gilbert reported on this issue.

Written by the local model on 2026-09-17, using this article's own text rather than the other coverage of the same event (that is the story summary below).

Signals How these are calculated →

Claims extracted

claim-shaped sentences

Uncertain

0 of 2 hedged

Leaning

not political

takes no side on a contested political question

Correction & hedging signals

77.1

corrections and hedging in what we collected; not a measure of accuracy

Outlets on this story

Health

Narrative spread

articles carrying this framing

AI analysis (generated at analysis time, not now)

Story summary

A CBS News investigation revealed that unapproved Eli Lilly weight loss drug Retatrutide, which is still in clinical trials, is being marketed and illegally sold to U.S. customers online by various companies. The report highlights significant regulatory concerns as Retatrutide has not yet been approved for public use, raising safety issues for consumers purchasing it from unverified sources.

Written for “Illegal Sale of Retatrutide” on 2026-09-17, grounded in this article and the 0 other(s) covering the same event.

Why this leaning score

This article does not take a side on a contested political question, so it has no leaning score. That is an answer rather than a gap: a match report or a rescue can be warmly or critically written without being left or right, and scoring it anyway is how approval of a subject gets recorded as a political position.

No political leaning scored for article 14955 · logged 2026-09-17

Story

📰 Illegal Sale of Retatrutide

Health · 1 article(s) covering the same event. This is the one the site leads with.

How this is being covered How these are calculated →

Article leaning vs. publisher reliability

Source leaning vs. consistency

Compared with similar articles

Nothing to compare against. No article is close enough to this one for the pipeline to have linked or judged the pair.

Publisher

CBS News · 555 article(s) · 2 correction(s) detected

Running correction rate · 2 correction(s)

2026-09-14

The AI bubble is leaking air, some economists say. Should investors worry?

2026-08-24

Sean Grayson, convicted in killing of Sonya Massey, dies in prison, attorney says

Who wrote this

No reporter is named on this article.

Topics

CBS News Eli Lily Retatrutide U.S. online

Subjects

CBS News ORG · 2× Eli Lily ORG · 2× Daniel Gilbert PERSON · 1× U.S. GPE · 1×

Narrative

Companies illegally selling unapproved Eli Lily weight loss drug Retatrutide online Retatrutide, an experimental weight loss drug still undergoing clinical trials at Eli Lily, is being marketed online and illegally sold to U.S. clients, a CBS News investigation found.

framing: assertive · carried by 1 article(s) · first seen 2026-09-17

2026-09-17 · CBS News

Companies illegally selling unapproved Eli Lily weight loss drug Retatrutide online · assertive framing

Claims (2 extracted, 0 hedged)

investigation → sell → clients

CBS News investigative reporter and producer Daniel Gilbert has the story. asserted

Gilbert → have → story

Companies illegally selling unapproved Eli Lily weight loss drug Retatrutide online

Summary